Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reboxetine for OSA after upper airway surgery
NCT05978505Phase 2Recruiting
- Sponsor
- Flinders University
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reboxetine in obstructive sleep apnea (OSA), sponsored by Flinders University. Started Aug 2023; status: recruiting.
02
Drugs
reboxetine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05978505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05978505.